Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › MEDANTA

MEDANTA

Global Health Limited
Mid-capHealthcare ↗

What the six lenses say about MEDANTA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1422.6
2026-09-08
VWAP · 1Y anchor
₹1253
+13.6% from VWAP
P/E · TTM
68.7×
TTM EPS ₹20.7
52-week range
84%
position low→high
RSI(14)
49
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How MEDANTA’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD888›

The actual numbers

Price vs VWAP (1y)+13.6%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+11.8%
Price vs 50-EMA+2.2%
RSI(14)49
RS vs Nifty 500 · 3M+13.1%
RS vs sector · 3M+10.4%
52-week range84%
Volume vs 30d avg0.63×
Volume vs 60d avg0.69×
ATR(14) · volatility53.9
Bollinger width · vol contraction0.084
FundamentalD973›

The actual numbers

Return on equity (ROE)15.2%
Return on capital (ROCE)17.1%
Operating margin18.0%
Net margin12.6%
Revenue growth · YoY+19.4%
EPS growth · YoY+15.5%
Debt / equity0.30×

Full 8-quarter history in the financials table below.

ValuationD25›

The actual numbers

P/E (TTM)68.7×
TTM EPS₹20.7
52-week range84%
CatalystD543›

The actual numbers

Earnings & momentum45
Capital actions10
Governance194

Every filing in the corporate-announcements panel below.

FlowD450›

The actual numbers

Promoter holding33.0%
Delivery · 30d avg55.5%
Up/down-day asymmetry3.1pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D8 + D4 ) ÷ 2 = 6.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
84
Conviction score 84/100 · avg-decile strength 6.0/10
Conviction score84/100›
TechnicalD8›
FundamentalD9›
ValuationD2›
CatalystD5›
FlowD4›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-2.7pp
-2.6pp
+2.0pp
+14.7pp
+30.9pp
+6.3pp
Nifty 500
Broad-market baseline
-2.8pp
-2.6pp
+0.9pp
+13.1pp
+25.1pp
+1.1pp
Sector
Own-sector index
—
—
-0.4pp
+10.4pp
+16.5pp
-12.2pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

MEDANTA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1422.60-47.20

Relative strength

RS vs baseline · rebased to 100

MEDANTA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
130.97-3.78

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)8619579439311,0311,0991,1211,159
↳ change QoQ—+11.1%-1.4%-1.3%+10.7%+6.6%+2.0%+3.4%
EBITDA (₹cr)208247254225247231217244
EBITDA margin24.2%25.8%26.9%24.2%24.0%21.0%19.4%21.1%
PAT (₹cr)10613114310115915895142
↳ change QoQ—+23.1%+9.2%-29.3%+57.4%-0.6%-39.9%+49.5%
Net margin12.3%13.7%15.1%10.8%15.4%14.4%8.5%12.3%
EPS (₹)3.964.875.323.785.925.893.545.36
D/E————————
YoY growth · Mar '26Revenue +24.5% YoYPAT +40.6% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 31 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 22 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 22 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 31 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Jul '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 30 Jul '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 30 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds MEDANTA

Mutual funds holding MEDANTA (10)

FundWeightAUM ₹crGrade
Kotak Midcap Reg Gr1.80%69,283
Canara Robeco Large & Mid Cap Reg Gr0.93%26,062
UTI Flexi Cap Reg Gr1.97%24,036
HDFC Multi Cap Reg Gr0.77%20,583
Invesco India Mid Cap Gr4.37%14,721
Invesco India Smallcap Reg Gr2.13%14,475
Canara Robeco Small Cap Reg Gr1.68%14,231
UTI Mid Cap Reg Gr1.14%12,379
Invesco India largecap Gr1.12%11,746
Invesco India large& mid cap Gr2.04%11,746

ETFs holding MEDANTA (3)

ETFWeightGrade
Groww BSE Hospitals ETF4.93%
Mirae Asset Nifty 500 Healthcare ETF0.86%
Motilal Oswal BSE Healthcare ETF0.75%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare